33 results
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
a shortage of skilled executives in our industry, which is likely to continue. As a result, competition for skilled personnel is intense and the turnover
424B4
QNRX
Quoin Pharmaceuticals Ltd
6 Mar 24
Prospectus supplement with pricing info
5:07pm
. There is currently a shortage of skilled executives in our industry, which is likely to continue. As a result, competition for skilled personnel is intense
424B3
QNRX
Quoin Pharmaceuticals Ltd
4 Mar 24
Prospectus supplement
5:27pm
scientific and technical personnel, will also be critical to our success. There is currently a shortage of skilled executives in our industry, which … is likely to continue. As a result, competition for skilled personnel is intense and the turnover rate can be high. We may not be able to attract and retain
424B4
fyn5cpmq4m4q5mhtt36
8 Aug 22
Prospectus supplement with pricing info
5:49pm
F-1/A
snlj6x52o3l89eyqd
4 Aug 22
Registration statement (foreign) (amended)
11:44am
F-1
ofeblfvnd0u7ioplln
2 Aug 22
Registration statement (foreign)
9:49pm
424B3
oclu3oti h1t
25 Apr 22
Prospectus supplement
6:40pm
F-1
p3pd5svtnf85
15 Apr 22
Registration statement (foreign)
12:00am
6-K
EX-99.1
2mvbv4f7r8p3jmxcz q9
8 Mar 22
Notice of Annual General Meeting of Shareholders
5:20pm
6-K
EX-99.3
ndep xpa1
24 Aug 21
Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
4:26pm
6-K
EX-99.2
1x6 12495bs2e
13 Aug 21
Current report (foreign)
5:21pm
F-4/A
lo0sbxqrkh ml6yh
10 Aug 21
Registration of securities (foreign) (amended)
3:22pm
F-4/A
ykzymusamw
5 Aug 21
Registration of securities (foreign) (amended)
9:24pm
F-4/A
miyjny9umq4mqlqyg 64
16 Jul 21
Registration of securities (foreign) (amended)
4:09pm
F-4
29d2p wemc5oma
16 Jun 21
Registration of securities (foreign)
4:40pm